Benjamin H. Lowentritt, MD, FACS reviews Real-World Head-to-Head Analyses Comparing Different Treatment Options for Metastatic Castration-Sensitive Prostate Cancer
Michael Johnson, MD, FACS and David Morris, MD, FACs discuss the value of real-world evidence and how it can be incorporated into daily practice to support shared decision-making. This webinar delves into key data from two recent head-to-head real-world analyses of androgen receptor pathway inhibitors to explore survival outcomes in metastatic castration-sensitive prostate cancer.
IBCG Bladder Cancer Disease State Awareness Webinar- Bladder Cancer Insights
Bladder Cancer Insights- Management of Non-Muscle Invasive Bladder Cancer (Part 1): High Risk
Bladder Cancer Insights- Diagnosis and Staging
Bladder Cancer Insights- Treatment Considerations with BCG
